iCRYO Announces Partnership with Therapeutic Manufacturer, BTL

BTL Industries main focus has been on non-invasive solutions to body shaping, muscle, skin tightening and other medical aesthetic treatments. Additionally, BTL has a key focus on health and wellness, with core competencies in both muscles and aesthetics, products backed by industry-leading clinical research, and a strong commitment to innovation with numerous patents and first-of-their-kind devices.

With more services being tested, iCRYO’s synergistic partnership with BTL is focused on the new non-invasive body shaping procedure, Emsculpt NEO®, as well as other devices in the BTL product line. BTL’s patented muscle-toning technology introduced an entirely new category to the aesthetic and wellness industries. Emsculpt NEO® combines HIFEM® and radiofrequency technology to tone muscle and break down fat in a 30-minute session.

“This partnership has paved the way for iCRYO to offer the most innovative technology available for our Guests.” stated Kyle Jones, Chief Innovation and Branding Officer of iCRYO.

“Truly a solid synergistic partnership all around.” stated Chuck Tripi – BTL Director U.S. Strategic Accounts.

Recently announcing the addition of Medical Ozone Ultraviolet Intravenous Therapy (Ozone UV IV Therapy) and NAD+ Intramuscular shots to its core services, iCRYO recognizes the importance of capitalizing on relevant trends. Each of these services are meant to complement the existing offerings, and provide a more customized and effective approach for guest needs.